With little being known about the predictors or moderators of dTMS outcome for OCD, this study sought to examine if several theoretically relevant variables may predict and moderate treatment effects including OCD symptom severity, functional impairment, co-occurring depressive symptoms, age, gender, age of OCD onset, and family history of OCD.
This clinical review assessed the use of exposure and response prevention therapy for patients with obsessive-compulsive disorder during the COVID-19 pandemic.
This study examines whether pretreatment brain activation during cognitive control and reward processing is associated with treatment response to CBT in patients with OCD.
In body dysmorphic disorder, the higher a patient’s readiness to change and confidence in cognitive behavioral therapy, the more likely the intervention will be successful.
Cognitive behavioral therapy and supportive psychotherapy can improve body dysmorphic disorder symptoms, but cognitive behavioral therapy is associated with more consistent improvements.
A study compared participants with clear diagnoses of either generalized anxiety disorder or obsessive-compulsive disorder with each other, as well as with controls, in order to identify cognitive differences between both groups.
Intensive residential treatment was found to be effective in reducing the symptoms of obsessive-compulsive disorder, although different response trajectories were observed.
Researchers examined whether adjunctive gabapentin or memantine and standard treatment with a selective serotonin-reuptake inhibitor (SSRI) might lead to further improvements in patients with OCD.
